Uchida Tetsuya
Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama-city, Tokyo, Japan.
Curr Drug Targets Immune Endocr Metabol Disord. 2003 Jun;3(2):119-35. doi: 10.2174/1568008033340252.
We previously reported that surface-linked liposomal antigen induced IgE-selective unresponsiveness. The results were consistent even when different coupling procedures for antigen with liposomes, or for liposomes with different lipid components, were employed. During the course of an investigation intended to clarify the mechanism of IgE-selective unresponsiveness induced by surface-coupled liposomal antigens, we discovered an alternative approach to regulate the production of IgE, one that is independent of the activity of T-cells. Immunization of mice with OVA-liposome conjugates induced IgE- selective unresponsiveness without apparent Th1 polarization. Neither interleukin-12 (IL-12), IL-10, nor CD8(+) T-cells participated in the regulation. Further, CD4(+) T-cells of mice immunized with OVA-liposome were capable of inducing antigen-specific IgE synthesis in athymic nude mice immunized with alum-adsorbed OVA. On the other hand, immunization of the recipient mice with OVA-liposome did not induce anti-OVA IgE production, even when CD4(+) T-cells of mice immunized with alum-adsorbed OVA were transferred. In the secondary immune response, OVA-liposome enhanced anti-OVA IgG antibody production but not the ongoing IgE production, suggesting that the IgE-selective unresponsiveness induced by the liposomal antigen involved direct effects on IgE but not IgG switching in vivo. These results suggest the role of an alternative mechanism, one not involving T-cells, in the regulation of IgE synthesis, and raise the possibility that surface-linked liposomal antigen is potentially applicable for the development of a novel vaccine that induces the least IgE synthesis. Moreover, given the relatively low allergic response to and increased antigenicity of the allergen, this form of antigen preparation would be applicable to allergen immunotherapy.
我们之前报道过,表面连接的脂质体抗原可诱导IgE选择性无反应性。即使采用不同的抗原与脂质体偶联方法,或使用具有不同脂质成分的脂质体,结果仍然一致。在旨在阐明表面偶联脂质体抗原诱导IgE选择性无反应性机制的研究过程中,我们发现了一种调节IgE产生的替代方法,该方法独立于T细胞活性。用OVA-脂质体偶联物免疫小鼠可诱导IgE选择性无反应性,且无明显的Th1极化。白细胞介素-12(IL-12)、IL-10和CD8(+) T细胞均未参与调节。此外,用OVA-脂质体免疫的小鼠的CD4(+) T细胞能够在用明矾吸附的OVA免疫的无胸腺裸鼠中诱导抗原特异性IgE合成。另一方面,用OVA-脂质体免疫受体小鼠,即使转移用明矾吸附的OVA免疫的小鼠的CD4(+) T细胞,也不会诱导抗OVA IgE产生。在二次免疫反应中,OVA-脂质体增强了抗OVA IgG抗体的产生,但没有增强正在进行的IgE产生,这表明脂质体抗原诱导的IgE选择性无反应性涉及对IgE的直接作用,而不是体内IgG的类别转换。这些结果表明存在一种不涉及T细胞的替代机制在IgE合成调节中的作用,并增加了表面连接的脂质体抗原可能适用于开发诱导最少IgE合成的新型疫苗的可能性。此外,鉴于对变应原的过敏反应相对较低且变应原性增加,这种形式的抗原制剂将适用于变应原免疫疗法。